Loading...

A targeted enzyme approach to sensitization of tyrosine kinase inhibitor-resistant breast cancer cells

Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) of potential use in patients with breast cancer. Unfortunately, in clinical studies, gefitinib is often ineffective indicating that resistance to EGFR inhibitors may be a common occurrence in cancer of the breast...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Giordano, Courtney R., Mueller, Kelly L., Terlecky, Laura J., Krentz, Kendra A., Bollig-Fischer, Aliccia, Terlecky, Stanley R., Boerner, Julie L.
Format: Artigo
Sprog:Inglês
Udgivet: 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3858180/
https://ncbi.nlm.nih.gov/pubmed/22687878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yexcr.2012.06.001
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!